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:,:.140 and/or DBP 390 mmHg) ranged from 48% in France to 61% in the 
Czech Republic, Elevated plasma total cholesterol (~5.5 stool/I) ranged from 
36% In Spain to 58% In italy, Diabetes ranged from 10% In the Nothedands 
to 27% In Hungary. A family hlstolv of premature CHD In e first degree blood 
relative ranged from 21% In Spain to 57% In Finland, These significant go. 
ogr.phlcal verlntlons In the prevalence of oardlovasculer risk fsctore In CHD 
pntl,,nts acro,s Europe partly reflect he incidence of cardiovascular disease 
In each country, aerie.economic onditions and Iho aHItudes of physicians to 
dsk factor modification and second(try prevention of coronary heart dlsoaso, 
~ ]  Twanty.Yur (1678-1998) Community-wide Tmnde 
................ In the Inoldonoe nnd In,hospital  Cl l l I -FI Ihl l i ty 
Rlt te l  (CFR'I) AlllOgllliod With Conge l t lv l  Heart 
Falluro (CHF) Complicating Acute MyOOllrdlal 
Infarction (AMI): The Womester Heart Attaek 
Study 
M. Hottoh. J. ¥~rzebskl, R, Goldboro, T, Meyer, J, Gore, The LIn/vwxify of 
Mes~ch~aelta M~It~I School, Woroo~ter, MA, USA 
Bl~¢t¢#lmUnd; Limited and re~ent population.based ata are ~vellsble about 
changes over time in the Incidence and CFR'R of CHF complloallng AML The 
goals 01 this mUlll.hospitsl commgnlty.wlde study warn to das~rlba temperer 
trends In the Incldenca and CFR's at CHF complloetlng AMI from a pepuia, 
lion.based perepeellve, 
Mefho~l~: 6,797 pallents with vslldsled AMI, and wdhout a pnor history 
0l CHF, hospitalized in ~tl Wome~ter, MA, metropolitan hospitals (1090 con, 
~lgS estimate =~ 470,000) In ten pen0ds between the years 1975 end 1995 
comprised the study sample, 
R~u~;  Declines in the unadjusted incidence retaa as woII as CFR's o! 
CHF were zeen In the five aggregated study penods: 
19'15f7S lp(tl/a4 1988,'88 1090/91 1083/95 
In -  1402) (n = 1431.1) in -  1231) in .  12~,0) in = 1407) 
In¢ld~n~ r~te= (~l  3n3 43,6 3?~ 35(t 33 1 
In.hoapIt~l CFR I%) I? ~ 15,4 10,1 131 112 
ConCtu,~vl: The reSUltS et this community-wide observational study sug- 
gest ancouregLng declines In the occurrence end hoapltal death rates of CHF 
In the setting of AMI, Despite those encouraging trende, CHF is a frequent 
complication of AMI, emphasizing the continued importance of continued sec- 
ondary prevention efforts. 
~ Coronar.i Disease Patients With Low 
Socioe©onom~© Status Have Higher Out-of-Pocket 
Medicat ion Expanses and Higher Non-cempllence 
Rates 
C,Y, Tung, L,C, Lam, N, ( :lapp-Channing, R, Harwood, R, Williams, 
J, Barefoot, I, Stagier, D. t. Malk, DukeCtinicaiFteseamh '~s~tute, Durham, 
North Carolina, USA 
Background: The mediators by whlc,~ socioeconomic status (SES) affect car- 
diac outcomes remain unclear. The purpose ot the study was to determine the 
effect ol low SES on out-of-pocket medication expenses and compliance. 
Methods: We prospectively studied 523 patients with coth proven coronary 
disease who wore treated medically In sltucturecl interviews, patients were 
e~ked about their average monthly ,~ut-of-pocket medication expenses and 
whether they have cut ('/own or stopped taking their medications because of 
cost. 
Results: 
Ed~.lcation Mods' C~,ltdown Incomo Mods' Cutdown 
6 yrs $119 .~B% - 10 k $107 20% 
• -1~ yrs $88 10% 10 k-20 k $109 15% 
13-16 yrs  $S6 5% 20 k-45 k $58 3% 
• 16 yts $66 5% .45 k $71 2% 
• Rverage monthly out-or-packet me¢lk~atton expenses, 
Conclusion: Out-of-pocket medication expenses for coronary disease pa- 
tients o1 low SES were nearly twice as high as those with higher SES The 
higher medication cost was associated with a five to ten fold higher medical 
non-compliance. Non-compliance with medieat herapy could inpart account 
for the woreo prognosis of low SES coronary disease patients, 
~ Socioeconomic Status and Medical Care Use In 
Coronary Disease Patients 
C.Y. Tung, L.C. Lam, N Clapp-Channing, B, Lytle, R. Williams, J. Barefoot, 
I. Siegler, D.B. Mark. Duke Clinical Research Institute, Durham, North 
Carolina, USA 
Background: Low socioeconomic status (SES) is associated with increased 
cardiovascular mortality, However, the mediators by which SES affect cardiac 
outcomes remain unsettled, One potential mediator Is pattern of medical cam 
USe, 
Methods: We pmspoctlvaly studied 523 patients with oath proven coronary 
disease who were treated medically. Medical care use was assessed at 6 
months. The definition for low SES was an income .:$10,000/yr and <9 wars 
of education, 
Results: Patients In the low SES group were older (68 ve, 63, p ,~ 0 01), had 
more hypedenslcn (78% va 57%, p < 0,001), were more likely to be lemala 
(49% ve 31%, p ,=, 0,0QOl), and more likely to t~ blick (34% vii 15%, p .~ 
0,001), Even thoug h the total number of outpr~tlent vlsite was not slgntl¢antty 
different (5,1 vs, 8, p = 0,73), the low SES group required more ER visits (0,3 
va, 0,1R, p .  0,01), but received lower ¢am~ac rahab viaitl (0 ve. 2.8, p - 
0005), There was no difference in hospllallzatlons, 
Conclusion: Coronary disease patients with low SES had more acute care 
vlslta, bgt received fewer preventive visit8 them other Ipet!ents, Thia different 
pattern of medloat care uzre could, in pad, account for the worse prognosis 
observed for law SES coronary disease patients, 
~ High Pmva!emm O! Left Ventdcular Hyper t rophy 
In Young Urban Black Man With Hypertens ion 
W,S, Post, J,L, Weiss, R~, Blumenthal, G. Gorstenblilh, A.R. CopseS, 
M,C, Roary, S, Hall, MT  Kim, M.N. Hi!l. Johns H~ms &4~)d/,cal tnstitutmns. 
Baltimore, Mary/and, USA 
Left ventriculsr hypertrophy (LVH) in hypertensive populations iS a potent 
predic;tor el adverse cardiovascular events, en imPortant pre~nm~r for the 
development of systolic and diastolic dysfunction, end may in l l~  the se- 
lectioh el appropriate therapy. Although its prevalence in some hyperten.~ve 
populations is described, the prevalence of LVH in young black hypeflensn~ 
men is not, 
We evaluated the prevalence of LVH in hypertensive young black men 18 
to 54 years old in East Baltimore who were ~rticipating in a ra l l~  study 
evaluating the effectiveness of a comprehensive community health wo~ker- 
nurse prectioner-phystcian team approach to Iowe~ blcocl pressure IBP) and 
decrease cardiovascular outcomes in this high risk group. Echecan:~ 
LV mass (LVM) was measured using the 2.D 5/6 area.length method. LVM 
was indexed ta height and LVH was defined as LVM index ~-~43 g~nn. ECG- 
LVH was detemliced using the Comell voltage dtefia. RaVL + Sv3 > 28 mV. 
O1 the hrst 106 men with hyT..~tl~nsion (HTN) at the baseline exam (SBP 
~: t 40 or DBP ~. 90) 9 with inadequate chocam'iogrems were excluded. In the 
mm~.ining 97, mean age was 3.q ~. 5 yearn, mean BP 154 ~L 19/104 ± 13 
mmHg and mean body mass index 25.9 =: 5.5 kg]n~.. Mean LVM was 214 ~. 
62gandmeanLVMindex 121 • 3401m.Theprevalencoolechecardiographic 
LVH was 22%. The prevalence of ECG-LVH was 14%. with a sensitivity of 28=0 
and specificity of 90% comparecl with echocardiographic LVH The correlation 
between sap and LVM index was r = 0.26, p = 0.0t, 
The Ngh prevalence ot echocardiograph=c LVH in inner city black hyper- 
rensive men may have important implications lot the evaluation and treatment 
el HTN and its consequences in this young high risk group. 
~ Excessive Prevalence of  Coronary Disease Risk 
Factors in Black Families With Premature 
Coronary Heart  Disease 
R.S, Blumenthal, ID.M. Becket, R.M. Yook, T.F. Moy, B.G Kral, L.C. Becker. 
The Johns Hopkins Medical Institutions. Bedsore. Maryland, USA 
Premature familial CHD and its associated risk factors have been studied al- 
most exclusively in white families. To determine the prevalence in blacks el 
hypertension end lipid abnormalities known to contribute to the risk of pre- 
mature CHD, 161 apparently healthy black siblings (SIBS) from 86 probands 
with CHD .60 years o1 age were examined and compared with sex and race 
matched reference populahons from the Third National Health and Nutntion 
Examination Survey (NHANES). Black SIBS had a mean age of 46 ~ 8 years, 
an educational level ot 12.8 ± 2 years, and were all free of known CHD. 
The data in the table show an excess prevalence l hypercholesterolemla 
and hypedension in black families with a history of premature CHD relative to 
black population orms, Aggres.~ive screening and treatment in black families 
~IBS NHANES p-vatue 
Black men (n = ~,4) 
LDL-C ~ 160 mg/dl 54% 17% - 0.01 
HDL-C. 35 rhg/dL 11% 11% 0.90 
Hypertension 59°0 34°0 . 001 
Black women (n = 107) 
LDL-C ~ 160 rag/d1 36% 15% •:0.01 
ttDL-C • 35 mg/dl 7°0 4°0 0.30 
Hypertension 52% 27% • 0,01 
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with known premature CHD IS important and may influence subsequent risk 
of early CHD in asymptomalJc family members. 
• HOI~I~/gOus Hyperchol~lt~rofemla Is Femllllll 
Common In Afdcefl Amerk~ns With Coronary 
Artery At l~¢ lero f l c  Dl~mse In Milwaukee 
A, Abr~md~m, S l ibu~, J, b, L, RafleI, R,C, O~v~, C,E, Gnm. M~x~.al 
C~Wj~ # W~¢on~ ~atv~ee, Wt: Ce~ra $~ M~(¢at Cemer, t~  
Ange~C~US~ 
He~roxygoul Famil~ ~ (hFH) =howl slnk. 
trig Mhe~ v~#on, In th~ US wt~e l~bo~ • 1/500; m F ~  Caned~ 
1,'20; m ~,uttt A ~  Af~m~m !/80; m C l~ ~ IF270. O~y 5 
ce.le~ m btt¢tm beve m,.~f b(~Lm mtl~Orte¢l (4 m U~M~ a.ed I m South Afnca), We_ 
au~' t  Ihe low tale kn US t~¢kz ~ because no e~e h~ ~ ~ ,  
AdbmP, em: OU~ an ol ou~ ~,~='l ~ n  F~,  I ,~n ~ Pm,~m 
v~ hav~ mermd leo ~ ~ ~ a ~ wit~ ~ ~m- 
new ar l~ an~e~ ~ (C~O), U=ng me ~ de~efoced by me 
MEI~I~D (Make_ I~ady I~Pmven l  Eady Dealh) program at the UnN. 
el Utah w~ h~ ~ ? ~ (4/7%) I~al mee! Ihe c ~  fo~ hFH: TC 
~ lhe value ot ~ tam~ ~oW and ~rmem~ as me mo~ 
Oft¢~ meg~od ~ f~d ~ ~ al ~e~/l~gh r~k f~ l~ematum death 
f m m a ~  
R~. -  New dmam ~ has sl~mm lha~ lovm~ chofesle~ ,~ 
sta~s m tamay mem~rs we ,~,~,~se mod~ and mona~, m me ~ar~ 
O! 0~r A~ ~ we ilium ~*ed 600 m and tasted 24 firsl m'~d 
~o,-,6 deg~e mlat~t~, 58% e~ ~om also have hFH 
~ ~- ,~ ~ :~-~9 
tJt0KI AQe = 47 ± 6 0% ~220 30% ~240 
TC 3~9 29;' 
HDL 60 3O 
27O 27O 
Ag~ *43 
0'% _-2~0 
~ -  hFH m edlter tmusuaily o~, ,on  m MilwauL, Be Alncan Amen- 
c=ns dua to a fo=-,Oe, eltect or me I~ig~ fat diet, low energy ezq~en,ttum typcal 
ol a city 1hat is 00~1 in ttte winter and hnt and hum=d m the summec 
Management Congestive Cost-Effective of  
Heart Failure 
Tuesday, March 31, 1998, Noon-2:00 p.m. 
Georgia Wodd Congress Center, West Exhibit Hall Level 
Presentation Hour:. 1:00 p.m.-2:00 p.m. 
-97 Ten Year Trends in Cam for Congestive Hospital 
Neart Failure: Improved Cu:comes. Increased 
Procedures and Higher Costs 
C.A. Polanczyk~ LE.P. Ro~de. M. CaiL T. DiSaNo. Massac/~etm Genera/ 
Hos, o~ak Bos~o,. MA. USA 
Chazcje~ o~er ttme in outcomes and resource u~l~zabon m ~ta l  care O1 
congestive heart failure (CHF) have no1 been widely stuched. To exan~ne 
tre~ls of mortality rates, resource utdizatJon and cosls in pabents edmittsd to 
an academic medical center, all 6,676 pahents hospitalized with pnman/ICD-9 
c~ag~:~ses of CHF between 1986 apd 1996 were ~ .  Palmer outcomes 
and resource utilizal~n were ~Lsk-adjusted for ~ i c  charac- 
tenstics and asso~aled comod~ties using muffiple regression analyses. A 
yearly, discount rate ol 7% was used 1o convert all costs to 1996 US~. 
Resu/ts (see table): The mean age was 70 + 13 years. 54% were male 
and 87% were white. FOr all trends, p value <0.01. Invas=ve prooedures = 
cardiac catheterization, PTCA. CABG, IABP, mechamcat ventilation, invas=ve 
hemedynamic monitoring and dialysis. 
Conclus~n: A significant decrease in hospital mortality was obsewed in 
a 10 year period, even after controlling for soc,o-demographic haracteristics 
Yearn 1986-87 1988--89 1990-91 1992-93 1994~96 
(n=942) (n=1126) (n=1302) (n=1411) (n=1896) 
ln-hospi~l mortals'y, % 8.4 8.5 7.1 6.3 6.1 
Ad~sted motla|~tv 9.1 8.8 6.7 5.7 6.4 
Invasive Procedures. % 19 21 24 28 24 
Length of stay. days 9.6 10.7 11.2 10.3 8.8 
Adjusted length of ~ay 104 11.0 10.9 9.9 8.9 
Total costs, 1996 US$ 2,814 4,182 7.036 10,760 12,759 
Adjusted total costs 2,800 4.107 6.913 10,579 13.039 
arx:l comod),dfflo8, Those data indcata that the decreM4) m mortallly was 
achmved at the aXlpenso o! increased procedure ulihzaho~ sad h~gher Overall 
hesp~tal co6ta, 
~ Impact of t tN I th  Imlur lm~ Status on Out .me in 
P l tkm~ With Advmn¢~l I t~r t  Failure RMm, red for 
Htmrt ' r ren lp lan~t!on 
JA. Wal(k~, M,A, Hell,lion, G,C. FoNifow, MJ~. Woo, NA I.Mngs1On, 
^, Hage, JD, Moftg~hi, UC/,A Me¢~ Cent,, to~ Ange~ CA, 
v~n¢~ hemt faikn~, we ~ BS3 ~ who were evaJuatad and ac- 
to~ bean ~n~pkmtaUon (l"x) t~tween lm2 and l~uge,/Ul pmmm 
were ~ at a ~nlm~m of ~ 2-3 monl~ m l~e l~an lai!wo ¢emer, t~t 
r, on-HMO pm had ¢imat~ ~ to ~ ~m.  Pmmm w~e ~ 
ba,~ed on the~¢ I ~  ~ ins~n, ece ¢overeoe ~ ana~ ¢o¢ 
~ at brae el mlewal, peR~ tr~nslp~lllecL ,=tat~m attime of Tx, 4m¢1 sur- 
vWal. In ~ four If~urance calt~gofi~, 168 (34%) pt~ had p~vale insurance 
(P), 123 (22%) ha~ managed ¢~re plans (HMO), 148 (aS%) hed MedC, me 
(MCfl), and t 04 (I 6%) had MedcaKI (MCD). A. 4 gn~pe had stricter 
el ilMe~s ~ at lime O! ~mral (mean ~ 52 y~. NYHA 35, LVEF 24). 
W~th average f/u of 19 mont~, no difference, were ~ m fotal modal~. 
Howe~. a g~er  pmpe~ of HMO pts ~md u~0e~ 1"I (20%), con~ 
pared Io P, MCR, and MCD (15%, 1~,  19% p < O.0C01, p = 0.02, p = 0.18) 
Addemmdly, fe~me HMO pts were able to ewo~ Tx (44%), compam~ fo P and 
MCD (5~%, 61% p = 0.04, p =, 0.0~). 
Cm~eumo~- ~ ovem~ mmm,,al was ~mitar aoo~ all mmeance 
groups, patieofs caverecl ~ ~ cam I~ns mqu=~l urgem heart 
uan=plama~on ~ f~lUe~ and ~e~e les~ likely ~ ave¢l ~ .  
~ access ~ a hea~ lm]um specudNy centre may help to maxn~,ze 
c~ca~ mb~y a~ anew pa~e~ to de~ ,ansp~a~o~ v~out adveme~ 
effec~g sun~al. 
~ Ide~l~in 9 Patients Risk for Recurrent at Hospnal 
Admission for Heart Failure 
EF ~ J.B. I :ke fden. / - i~ Fotz/Ho~0~a/. Deh~L Aft& Ba~mett 
Hea~ca~e. C~,s lown.  N~. USA 
Ba~mpta~- Recurrent hospital adm~s~on~ for HF are &arrmngty common; 
Me,Jxx~: Usmcj b,~e New Yo~ sla~,;,~ hc,-~mial data set we compamcl the 
bet,~men 9,112 palm~ts ~ only 1 HF acb~s~io~ and 33,619 w~ll 
>1 during 1995: ~ .  ~ illness, hos~tal l ype / Io (~ L~Xt 
processes of care. A simple readm~ss~ort Risk Score was denved by count- 
=p.g Itte number of pesdwe pred~ors present minus the number ot neg,ztwa 
predictors 
Results: Reg=b~ss,on was independontty related to I~k  inca. ~ i d  
a~d MedCare msuranoe, ~;;-,,~ ~=ptal, tek~e~ monit~ng, disc~rge 
against advK:e, and these ~ :  molemic and valvular head dis- 
ease. k.~,,~tttic caraiomyopalhy. ~ i~.  renal disease, COPD, ~ heart 
surgmy, benpl~eral vascular disease and anem~. Di~pdaarge to a numing 
home. carc~ac ath and ~ were retat~ 1o k.'wer isk. ~ 
~s the incremental mlabonsh,p between Rink Score and read , l t t~ rate: 
Score Rate Score Rate Score Rate 
3 to 0 9 6",, 3 20.0% 6 29.7% 
1 13.6% 4 23.1% 7 34 ~,~ 
2 166% 5 263% ;8 400% 
Conc~usiorts: 11 Using a large, co.-nl~rehensNe data set not restrcted by 
insurance payor, we identttied s~gnificant preo%~ors O1 recurrent aoYnffiston for 
HF: 2) our simple Risk Score fright be used to ,dentify candidates for care 
management o reduce readmissions 
~ W n a t  Matters to Patients With Severe Heart Really 
Failure: Tradeoffs Between Quantity and Qua l i~  
of Life 
K.D. Aaronson. J HoaShi, J. Bowers. T.-M. Chen. UnwersttyofM~h~gan 
Medical Center, Ann Arbor. ML USA 
Background: Although development and approval of drugs for CHF is largely 
focused on improving sun~ival, a drug's impact on quantity of life may differ 
from its effect on quality of life (QOL). How patients (pts) w~h severe CHF 
value quantity vs. QOL is unknown. 
Methods: We assessed the willingness of outpatients with chronic NYHA 
class III (n = 44) or IV (n = 3) CHF to accept decreased (~uant~ty to obtain im- 
proved QOI_ QOL was assessed with the Living with Heart Failure Question- 
naire (LHFQ). Utility for CHF-related QOL w~s assessed ~' st=_ndard gamble 
